These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34653311)

  • 21. Vascular endothelial growth factor-C modulates cortical NMDA receptor activity in cortical lesions of young patients and rat model with focal cortical dysplasia.
    Shen KF; Duan QT; Duan W; Xu SL; An N; Ke YY; Wang LT; Liu SY; Yang H; Zhang CQ
    Brain Pathol; 2022 Sep; 32(5):e13065. PubMed ID: 35259773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic spine loss in epileptogenic Type II focal cortical dysplasia: Role of enhanced classical complement pathway activation.
    Rossini L; De Santis D; Cecchini E; Cagnoli C; Maderna E; Cartelli D; Morgan BP; Torvell M; Spreafico R; di Giacomo R; Tassi L; de Curtis M; Garbelli R
    Brain Pathol; 2023 May; 33(3):e13141. PubMed ID: 36564349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasonographic features of focal cortical dysplasia and their relevance for epilepsy surgery.
    Akeret K; Bellut D; Huppertz HJ; Ramantani G; König K; Serra C; Regli L; Krayenbühl N
    Neurosurg Focus; 2018 Sep; 45(3):E5. PubMed ID: 30173618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perampanel: A Review in Drug-Resistant Epilepsy.
    Frampton JE
    Drugs; 2015 Sep; 75(14):1657-68. PubMed ID: 26370209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors.
    Hanada T
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32197322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perampanel: a novel antiepileptic for the adjunctive treatment of refractory partial onset seizures.
    Owen RT
    Drugs Today (Barc); 2013 Jan; 49(1):23-31. PubMed ID: 23362493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perampanel (Fycompa) for epilepsy.
    Med Lett Drugs Ther; 2014 Feb; 56(1435):9-10. PubMed ID: 24662975
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular insights into the role of AMPA receptors in the synaptic plasticity, pathogenesis and treatment of epilepsy: therapeutic potentials of perampanel and antisense oligonucleotide (ASO) technology.
    Charsouei S; Jabalameli MR; Karimi-Moghadam A
    Acta Neurol Belg; 2020 Jun; 120(3):531-544. PubMed ID: 32152997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perampanel tolerability in children and adolescents with focal epilepsy: Effects on behavior and executive functions.
    Operto FF; Pastorino GMG; Mazza R; Di Bonaventura C; Matricardi S; Verrotti A; Carotenuto M; Viggiano A; Coppola G; Elia M
    Epilepsy Behav; 2020 Feb; 103(Pt A):106879. PubMed ID: 31937512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the noncompetitive AMPA receptor antagonist perampanel on thalamo-cortical excitability: A study of high-frequency oscillations in somatosensory evoked potentials.
    Lanzone J; Boscarino M; Ricci L; Insola A; Tombini M; Di Lazzaro V; Assenza G
    Clin Neurophysiol; 2021 May; 132(5):1049-1056. PubMed ID: 33743300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of anti-seizure medications on ionotropic glutamate receptors: special focus on AMPA receptor subunits.
    Fukushima K; Hatanaka K; Sagane K; Ido K
    Epilepsy Res; 2020 Nov; 167():106452. PubMed ID: 32911258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy.
    Chonan M; Saito R; Kanamori M; Osawa SI; Watanabe M; Suzuki H; Nakasato N; Tominaga T
    Neurol Med Chir (Tokyo); 2020 Jan; 60(1):37-44. PubMed ID: 31748440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perampanel: as adjunctive therapy in patients with partial-onset seizures.
    Plosker GL
    CNS Drugs; 2012 Dec; 26(12):1085-96. PubMed ID: 23179642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in the pharmacotherapy of epilepsy: brivaracetam and perampanel as broad-spectrum antiseizure drugs for the treatment of epilepsies and status epilepticus.
    Willems LM; Bauer S; Rosenow F; Strzelczyk A
    Expert Opin Pharmacother; 2019 Oct; 20(14):1755-1765. PubMed ID: 31264486
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term seizure outcome in 211 patients with focal cortical dysplasia.
    Fauser S; Essang C; Altenmüller DM; Staack AM; Steinhoff BJ; Strobl K; Bast T; Schubert-Bast S; Stephani U; Wiegand G; Prinz M; Brandt A; Zentner J; Schulze-Bonhage A
    Epilepsia; 2015 Jan; 56(1):66-76. PubMed ID: 25495786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and impact on cognitive functions and quality of life of perampanel as first add-on therapy in patients with epilepsy: A retrospective study.
    Rea R; Traini E; Renna R; Pagliuca F; Pezzella M; Pagliuca M
    Epilepsy Behav; 2019 Sep; 98(Pt A):139-144. PubMed ID: 31374469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre.
    Morano A; Fattouch J; Albini M; Casciato S; Fanella M; Basili LM; Viganò A; Manfredi M; Giallonardo AT; Di Bonaventura C
    J Neurol Sci; 2018 Jul; 390():67-74. PubMed ID: 29801910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of focal cortical dysplasia Type IIIa on seizure outcome following anterior mesial temporal lobe resection for the treatment of epilepsy.
    Dührsen L; Sauvigny T; House PM; Stodieck S; Holst B; Matschke J; Schön G; Westphal M; Martens T
    J Neurosurg; 2018 Jun; 128(6):1668-1673. PubMed ID: 28753112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-duration epilepsy affects cell morphology and glutamatergic synapses in type IIB focal cortical dysplasia.
    Finardi A; Colciaghi F; Castana L; Locatelli D; Marras CE; Nobili P; Fratelli M; Bramerio MA; Lorusso G; Battaglia GS
    Acta Neuropathol; 2013 Aug; 126(2):219-35. PubMed ID: 23793416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulation of Astroglial TASK-1 K
    Lee DS; Kim TH; Park H; Kang TC
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.